iShares Nasdaq Biotechnology ETF Stock Forecast, Price & News

iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Frequently Asked Questions

What stocks does MarketBeat like better than iShares Nasdaq Biotechnology ETF?

Wall Street analysts have given iShares Nasdaq Biotechnology ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iShares Nasdaq Biotechnology ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has iShares Nasdaq Biotechnology ETF's stock been impacted by Coronavirus?

iShares Nasdaq Biotechnology ETF's stock was trading at $106.97 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IBB stock has increased by 47.6% and is now trading at $157.92.
View which stocks have been most impacted by COVID-19.

How often does iShares Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for iShares Nasdaq Biotechnology ETF?

iShares Nasdaq Biotechnology ETF declared a quarterly dividend on Thursday, September 23rd. Stockholders of record on Monday, September 27th will be paid a dividend of $0.124 per share on Thursday, September 30th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date is Friday, September 24th. This is a positive change from iShares Nasdaq Biotechnology ETF's previous quarterly dividend of $0.06.
View iShares Nasdaq Biotechnology ETF's dividend history.

Is iShares Nasdaq Biotechnology ETF a good dividend stock?

iShares Nasdaq Biotechnology ETF pays an annual dividend of $0.34 per share and currently has a dividend yield of 0.22%.
View iShares Nasdaq Biotechnology ETF's dividend history.

When did iShares Nasdaq Biotechnology ETF's stock split? How did iShares Nasdaq Biotechnology ETF's stock split work?

iShares Nasdaq Biotechnology ETF's stock split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

Who are iShares Nasdaq Biotechnology ETF's key executives?

iShares Nasdaq Biotechnology ETF's management team includes the following people:

• George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees
• Michael Arthur Latham, President, Trustee
• Jack Gee, Chief Financial Officer, Treasurer
• Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
• , Bio & Compensation - 
• Amy Schioldager, Executive Vice President
• Ira P. Shapiro, Vice President, Chief Legal Officer
• Matt Tucker, Vice President
• , Bio & Compensation - 
• Eilleen M. Clavere, Secretary
• Cecilia H. Herbert, Independent Trustee
• Charles A. Hurty, Independent Trustee

Who are some of iShares Nasdaq Biotechnology ETF's key competitors?

Some companies that are related to iShares Nasdaq Biotechnology ETF include iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD), iShares MSCI Emerging Markets ETF (EEM), SPDR Dow Jones Industrial Average ETF Trust (DIA), Consumer Discretionary Select Sector SPDR Fund (XLY), SPDR Bloomberg Barclays High Yield Bond ETF (JNK), SPDR Nuveen Barclays Short Term Municipal Bond ETF (SHM), SPDR Nuveen Barclays Municipal Bond ETF (TFI), DNP Select Income Fund (DNP), Direxion Daily Financial Bull 3X Shares (FAS), iShares MSCI Pacific ex Japan ETF (EPP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), Hercules Capital (HTGC), WisdomTree Emerging Markets High Dividend Fund (DEM) and Royce Value Trust (RVT).
View all of IBB's competitors.

What other stocks do shareholders of iShares Nasdaq Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), The Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).

What is iShares Nasdaq Biotechnology ETF's stock symbol?

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

Who are iShares Nasdaq Biotechnology ETF's major shareholders?

iShares Nasdaq Biotechnology ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include SpiderRock Advisors LLC (0.00%), Albion Financial Group UT (0.18%), Rye Brook Capital LLC (0.10%), McGuire Investment Group LLC (0.10%), Toth Financial Advisory Corp (0.10%) and CHURCHILL MANAGEMENT Corp (0.09%).

Which institutional investors are selling iShares Nasdaq Biotechnology ETF stock?

IBB stock was sold by a variety of institutional investors in the last quarter, including Altfest L J & Co. Inc., Stratos Wealth Advisors LLC, CHURCHILL MANAGEMENT Corp, Pinnacle Associates Ltd., CAPROCK Group Inc., M&R Capital Management Inc., NEXT Financial Group Inc, and Founders Capital Management.

Which institutional investors are buying iShares Nasdaq Biotechnology ETF stock?

IBB stock was bought by a variety of institutional investors in the last quarter, including Albion Financial Group UT, Crescent Capital Consulting LLC, Kestra Advisory Services LLC, Private Advisor Group LLC, Rye Brook Capital LLC, Latitude Advisors LLC, Koshinski Asset Management Inc., and Canton Hathaway LLC.

How do I buy shares of iShares Nasdaq Biotechnology ETF?

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Nasdaq Biotechnology ETF's stock price today?

One share of IBB stock can currently be purchased for approximately $157.92.

How much money does iShares Nasdaq Biotechnology ETF make?

iShares Nasdaq Biotechnology ETF has a market capitalization of $10.15 billion.